GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Catalyst Biosciences Inc (FRA:HGF2) » Definitions » 6-1 Month Momentum %

Catalyst Biosciences (FRA:HGF2) 6-1 Month Momentum % : 146.23% (As of Jun. 20, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Catalyst Biosciences 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-06-20), Catalyst Biosciences's 6-1 Month Momentum % is 146.23%.

The industry rank for Catalyst Biosciences's 6-1 Month Momentum % or its related term are showing as below:

FRA:HGF2's 6-1 Month Momentum % is not ranked
in the Biotechnology industry.
Industry Median: -4.78 vs FRA:HGF2: 146.23

Competitive Comparison of Catalyst Biosciences's 6-1 Month Momentum %

For the Biotechnology subindustry, Catalyst Biosciences's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Catalyst Biosciences's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Catalyst Biosciences's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Catalyst Biosciences's 6-1 Month Momentum % falls into.



Catalyst Biosciences  (FRA:HGF2) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Catalyst Biosciences  (FRA:HGF2) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Catalyst Biosciences 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Catalyst Biosciences's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Catalyst Biosciences (FRA:HGF2) Business Description

Traded in Other Exchanges
N/A
Address
611 Gateway Boulevard, Suite 710, South San Francisco, CA, USA, 94080
Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop valuable therapies for individuals with hemophilia. It is engaged in the clinical development of improved, next-generation subcutaneous prophylaxis using enhanced potency Factor VIIa and Factor IX variants.

Catalyst Biosciences (FRA:HGF2) Headlines

No Headlines